“PREVALENCE, CAUSE, AND PRESCRIPTION TREND IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND MEMBRANOUS TONSILLITIS”, Int. Res. J. Pharm., vol. 4, no. 2, pp. 175–180, Feb. 2013, doi: 10.56802/g7sd6f49.